Clinical Trials in Seattle

Showing 3481-3500 of 9,312 trials

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

NCT03319082

The objectives of this post market registry are to evaluate the safety and durability of treatment effect up to 3 years following cross-linking performed with Photrexa Viscous (riboflavin 5'- phosphate in 20% dextran ophthalmic solution), Photrexa (riboflavin 5'- phosphate ophthalmic solution), and the KXL System in patients with corneal ectasia following refractive surgery.

Corneal Ectasia

Glaukos Corporation200 participantsStarted Oct 2017

Palo Alto, California, United States • Bloomington, Minnesota, United States • Bozeman, Montana, United States +8 more locations

COMPLETED< 1 mile

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

NCT03788746

The purpose of this study is to assess the prevalence of pre-treatment tumor tissue PD-L1 expression in patients diagnosed with advanced urothelial carcinoma.

Urothelial Carcinoma

AstraZeneca181 participantsStarted Jan 2019

Little Rock, Arkansas, United States • Glendale, California, United States • Los Angeles, California, United States +55 more locations

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

Find Trials by Condition in Seattle

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

Pediatric KIDney Stone (PKIDS) Care Improvement Network

A Test-Drive Strategy for the Prescription of Prosthetic Feet for People With Leg Amputations

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

Cardiac Rehab Post-atrial Fib Ablation

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

Canadian Fabry Disease Initiative (CFDI) National Registry

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

Phase 3 Study of SNF472 for Calciphylaxis

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM